Groups
Conversations
All groups and messages
Send feedback to Google
Help
Training
Sign in
Groups
MyVisionTest
Conversations
About
MyVisionTest
Contact owners and managers
1–30 of 675
Mark all as read
Report group
0 selected
MyVisionTest
2/27/12
Role of genetics in progression through various stages of AMD
A new study finds that genes in different pathways influence progression to different stages of age-
unread,
Role of genetics in progression through various stages of AMD
A new study finds that genes in different pathways influence progression to different stages of age-
2/27/12
MyVisionTest
2/26/12
Risk Assessment Models for Late AMD
When patients are told by their ophthalmologist that they have early signs of age-related macular
unread,
Risk Assessment Models for Late AMD
When patients are told by their ophthalmologist that they have early signs of age-related macular
2/26/12
MyVisionTest
2/26/12
Risk score for geographic atrophy
Researchers have developed a risk score for developing geographic atrophy (GA) involving easily
unread,
Risk score for geographic atrophy
Researchers have developed a risk score for developing geographic atrophy (GA) involving easily
2/26/12
MyVisionTest
2/26/12
New AMD risk calculator
Researchers have designed a new risk assessment model for development of advanced age-related macular
unread,
New AMD risk calculator
Researchers have designed a new risk assessment model for development of advanced age-related macular
2/26/12
MyVisionTest
2/25/12
The role of genetic markers and environmental factors in the development of AMD
A new study finds that the gene for complement factor H (CFH) confers more risk to the bilaterality
unread,
The role of genetic markers and environmental factors in the development of AMD
A new study finds that the gene for complement factor H (CFH) confers more risk to the bilaterality
2/25/12
MyVisionTest
2/24/12
Genetic model estimates risk of developing wet AMD
AMD has been one of the success stories of the genome revolution and is probably one of the best
unread,
Genetic model estimates risk of developing wet AMD
AMD has been one of the success stories of the genome revolution and is probably one of the best
2/24/12
MyVisionTest
2/18/12
Genetic factors determine outcome of PDT for AMD
A new study finds an association between complement factor H (CFH), high-temperature requirement A-1
unread,
Genetic factors determine outcome of PDT for AMD
A new study finds an association between complement factor H (CFH), high-temperature requirement A-1
2/18/12
MyVisionTest
2/16/12
High AMD risk genotypes respond better to Lucentis therapy
A new study finds that among patients with wet AMD those with higher risk genotypes response better
unread,
High AMD risk genotypes respond better to Lucentis therapy
A new study finds that among patients with wet AMD those with higher risk genotypes response better
2/16/12
MyVisionTest
2/15/12
AMD treatment response to Lucentis influenced by genetics
Age-related macular degeneration (AMD) has a complex etiology arising from genetic and environmental
unread,
AMD treatment response to Lucentis influenced by genetics
Age-related macular degeneration (AMD) has a complex etiology arising from genetic and environmental
2/15/12
MyVisionTest
2/14/12
Diet can decrease the genetic risk of developing AMD
A new study finds that high dietary intake of nutrients with antioxidant properties reduces the risk
unread,
Diet can decrease the genetic risk of developing AMD
A new study finds that high dietary intake of nutrients with antioxidant properties reduces the risk
2/14/12
MyVisionTest
2/14/12
Update on the role of genetics in AMD
Extensive epidemiologic and genetic analyses have lead to the conclusion that AMD, like many other
unread,
Update on the role of genetics in AMD
Extensive epidemiologic and genetic analyses have lead to the conclusion that AMD, like many other
2/14/12
MyVisionTest
2/12/12
Lutein supplementation benefits AMD patients with low macular pigment
A new study finds that lutein supplementation increases MPOD, and a correlation was found between the
unread,
Lutein supplementation benefits AMD patients with low macular pigment
A new study finds that lutein supplementation increases MPOD, and a correlation was found between the
2/12/12
MyVisionTest
2/11/12
Lutein and zeaxanthin improve vision function in early AMD
Lutein-only and zeaxanthin-only supplementation for 12 months each increased macular pigment optical
unread,
Lutein and zeaxanthin improve vision function in early AMD
Lutein-only and zeaxanthin-only supplementation for 12 months each increased macular pigment optical
2/11/12
MyVisionTest
2/11/12
Lutein intake decreases risk of late but not early AMD
The findings of a meta-analysis indicate that dietary lutein and zeaxanthin is not significantly
unread,
Lutein intake decreases risk of late but not early AMD
The findings of a meta-analysis indicate that dietary lutein and zeaxanthin is not significantly
2/11/12
MyVisionTest
2/9/12
Omega-3 and fish intake may prevent AMD
A prospective study finds that regular consumption of fish oil and fish was associated with a
unread,
Omega-3 and fish intake may prevent AMD
A prospective study finds that regular consumption of fish oil and fish was associated with a
2/9/12
MyVisionTest
1/16/12
Eylea demonstrating strong results at 2 years
A phase 3 study of the efficacy of Eylea injections to treat neovascular AMD has shown sustained
unread,
Eylea demonstrating strong results at 2 years
A phase 3 study of the efficacy of Eylea injections to treat neovascular AMD has shown sustained
1/16/12
MyVisionTest
1/16/12
Regeneron, Genentech partially settle Eylea patent issue
Genentech and Regeneron Pharmaceuticals have agreed to a partial settlement with regard to ophthalmic
unread,
Regeneron, Genentech partially settle Eylea patent issue
Genentech and Regeneron Pharmaceuticals have agreed to a partial settlement with regard to ophthalmic
1/16/12
MyVisionTest
1/16/12
Race and AMD
Age-related Macular Degeneration (AMD) has long been thought to be more frequent in non-Hispanic
unread,
Race and AMD
Age-related Macular Degeneration (AMD) has long been thought to be more frequent in non-Hispanic
1/16/12
MyVisionTest
1/16/12
Incidence and progression of AMD in Latinos
The 4-year incidence and progression of age-related macular degeneration (AMD) in Latinos are lower
unread,
Incidence and progression of AMD in Latinos
The 4-year incidence and progression of age-related macular degeneration (AMD) in Latinos are lower
1/16/12
MyVisionTest
1/16/12
Ocular factors associated with AMD in Latinos
The Latino Eye Study found that ocular factors such as cataract, cataract surgery, and refractive
unread,
Ocular factors associated with AMD in Latinos
The Latino Eye Study found that ocular factors such as cataract, cataract surgery, and refractive
1/16/12
MyVisionTest
1/16/12
AMD risk factors in Latinos
The Latino Eye Study identified older age and higher pulse pressure as risk factors for 4-year
unread,
AMD risk factors in Latinos
The Latino Eye Study identified older age and higher pulse pressure as risk factors for 4-year
1/16/12
MyVisionTest
1/16/12
Racial differences in AMD
Racial minorities, including Latinos and Asian Americans, do not appear to have similar risks of
unread,
Racial differences in AMD
Racial minorities, including Latinos and Asian Americans, do not appear to have similar risks of
1/16/12
MyVisionTest
1/15/12
How will the CATT results impact clical practice?
The long-awaited primary outcome of the Comparison of Age-related Macular Degeneration Treatments
unread,
How will the CATT results impact clical practice?
The long-awaited primary outcome of the Comparison of Age-related Macular Degeneration Treatments
1/15/12
MyVisionTest
1/15/12
CATT findings suggest Avastin not as good with more adverse reactions
The much anticipated CATT study has now been published. The National Eye Institute is to be applauded
unread,
CATT findings suggest Avastin not as good with more adverse reactions
The much anticipated CATT study has now been published. The National Eye Institute is to be applauded
1/15/12
MyVisionTest
1/14/12
CATT findings support use of Avastin as alternative to Lucentis
For 5 years, patients and clinicians have wrestled with the choice between two drugs for the
unread,
CATT findings support use of Avastin as alternative to Lucentis
For 5 years, patients and clinicians have wrestled with the choice between two drugs for the
1/14/12
MyVisionTest
1/14/12
Severe inflammation caused by Avastin obtained from a single batch
The authors report a cluster of 14 consecutive cases of sterile endophthalmitis occurred after
unread,
Severe inflammation caused by Avastin obtained from a single batch
The authors report a cluster of 14 consecutive cases of sterile endophthalmitis occurred after
1/14/12
MyVisionTest
1/14/12
Sustained elevated intraocular pressures after intravitreal injection of anti-VEGF agents
Elevated intraocular pressure (IOP) after an intravitreal injection of anti-vascular endothelial
unread,
Sustained elevated intraocular pressures after intravitreal injection of anti-VEGF agents
Elevated intraocular pressure (IOP) after an intravitreal injection of anti-vascular endothelial
1/14/12
MyVisionTest
1/14/12
Receiving more anti-VEGF injections increases risk of glaucoma
Neovascular age-related macular degeneration (AMD) patients undergoing unilateral intravitreal
unread,
Receiving more anti-VEGF injections increases risk of glaucoma
Neovascular age-related macular degeneration (AMD) patients undergoing unilateral intravitreal
1/14/12
MyVisionTest
1/14/12
Questioning the systemic safety of Avastin
Intraocular injections of anti–vascular endothelial growth factor (VEGF) agents have yielded dramatic
unread,
Questioning the systemic safety of Avastin
Intraocular injections of anti–vascular endothelial growth factor (VEGF) agents have yielded dramatic
1/14/12
MyVisionTest
1/14/12
Ocular complications of anti–VEGF therapy for AMD
Anti–vascular endothelial growth factor (VEGF) treatment for neovascular age-related macular
unread,
Ocular complications of anti–VEGF therapy for AMD
Anti–vascular endothelial growth factor (VEGF) treatment for neovascular age-related macular
1/14/12